Rockwell Medical Holds Shareholder Vote
Ticker: RMTI · Form: 8-K · Filed: May 23, 2024 · CIK: 1041024
| Field | Detail |
|---|---|
| Company | Rockwell Medical, Inc. (RMTI) |
| Form Type | 8-K |
| Filed Date | May 23, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: RMED
TL;DR
RMED shareholders voted on key company matters, outcome TBD.
AI Summary
On May 21, 2024, Rockwell Medical, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing indicates a meeting or vote took place concerning important corporate decisions. Specific details regarding the proposals voted on or the outcome of the vote were not provided in this initial filing.
Why It Matters
Shareholder votes are critical for corporate governance, impacting strategic decisions and the direction of the company. The outcome can influence stock performance and investor confidence.
Risk Assessment
Risk Level: low — This filing is procedural, reporting on a shareholder vote without immediate financial implications or significant operational changes.
Key Players & Entities
- ROCKWELL MEDICAL, INC. (company) — Registrant
- May 21, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 30142 S. Wixom Road, Wixom, Michigan 48393 (address) — Principal executive offices
FAQ
What specific matters were submitted for a vote by Rockwell Medical, Inc. security holders?
The filing does not specify the exact matters submitted for a vote, only that such a submission occurred on May 21, 2024.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 21, 2024.
What is Rockwell Medical, Inc.'s state of incorporation?
Rockwell Medical, Inc. is incorporated in Delaware.
Where are Rockwell Medical, Inc.'s principal executive offices located?
The principal executive offices are located at 30142 S. Wixom Road, Wixom, Michigan 48393.
What is the Commission File Number for Rockwell Medical, Inc.?
The Commission File Number for Rockwell Medical, Inc. is 000-23661.
Filing Stats: 498 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-05-23 17:12:01
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 RMTI Nasdaq Capital Market Indicate b
Filing Documents
- rmti-20240521.htm (8-K) — 40KB
- 0001628280-24-025011.txt ( ) — 161KB
- rmti-20240521.xsd (EX-101.SCH) — 2KB
- rmti-20240521_lab.xml (EX-101.LAB) — 21KB
- rmti-20240521_pre.xml (EX-101.PRE) — 12KB
- rmti-20240521_htm.xml (XML) — 3KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On May 21, 2024, Rockwell Medical, Inc. held its 2024 Annual Meeting of the Stockholders (the "Annual Meeting"). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows: Proposal One: To elect the two Class III directors to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his successor has been duly elected and qualified. For Against Abstain Broker Non-Votes Robert S. Radie 11,524,139 160,366 48,056 8,117,274 Mark Strobeck, Ph.D. 11,517,800 164,730 50,031 8,117,274 Proposal Two: To approve, on an advisory basis, the compensation of the Company's named executive officers. For Against Abstain Broker Non-Votes 11,126,598 522,245 83,718 8,117,274 Proposal Three: To ratify the selection of EisnerAmper LLP as the Company's independent registered public accounting firm for 2024. For Against Abstain 19,446,483 210,240 193,112 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROCKWELL MEDICAL, INC. Date: May 23, 2024 By: /s/ Mark Strobeck Mark Strobeck Chief Executive Officer